Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Aug 31, 2025 | (FY)Feb 28, 2025 | (Q6)Aug 31, 2024 | (FY)Feb 29, 2024 | (Q6)Aug 31, 2023 | (FY)Feb 28, 2023 | (Q6)Aug 31, 2022 | (FY)Feb 28, 2022 | (Q6)Aug 31, 2021 | (FY)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 44.66%133.39M | 37.75%206.92M | 52.03%92.21M | 67.36%150.22M | 53.22%60.65M | -15.07%89.76M | -9.97%39.59M | 195.14%105.68M | 597.90%43.97M | -45.42%35.81M |
| Operating income | 44.66%133.39M | 37.75%206.92M | 52.03%92.21M | 67.36%150.22M | 53.22%60.65M | -15.07%89.76M | -9.97%39.59M | 195.14%105.68M | 597.90%43.97M | -45.42%35.81M |
| Other costs | -43.24%-119.71M | -35.17%-182.21M | -57.43%-83.58M | -93.12%-134.8M | -61.42%-53.09M | 28.11%-69.81M | 13.69%-32.89M | -221.37%-97.1M | -512.59%-38.11M | 34.42%-30.22M |
| Operating expenses | -43.24%-119.71M | -35.17%-182.21M | -57.43%-83.58M | -93.12%-134.8M | -61.42%-53.09M | 28.11%-69.81M | 13.69%-32.89M | -221.37%-97.1M | -512.59%-38.11M | 34.42%-30.22M |
| Gross profit | 58.42%13.67M | 60.31%24.71M | 14.12%8.63M | -22.74%15.41M | 12.95%7.56M | 132.63%19.95M | 14.27%6.7M | 53.39%8.58M | 7,316.46%5.86M | -71.37%5.59M |
| Administrative expenses | -12.52%-6.54M | -19.16%-16.18M | -24.71%-5.81M | -18.85%-13.58M | 14.71%-4.66M | 0.27%-11.42M | -20.26%-5.47M | 2.44%-11.45M | 29.88%-4.55M | -4.33%-11.74M |
| Impairment and provision | ---- | -462.50%-406K | ---- | 107.44%112K | ---- | -349.55%-1.51M | ---- | 79.94%-335K | ---- | -642.22%-1.67M |
| -Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.47M |
| -Other impairment is provision | ---- | -462.50%-406K | ---- | 107.44%112K | ---- | -349.55%-1.51M | ---- | -69.19%-335K | ---- | 12.00%-198K |
| Special items of operating profit | 2.16%1.09M | -1.50%1.44M | 93.99%1.07M | -4.31%1.47M | -62.22%549K | -54.13%1.53M | 4.01%1.45M | -26.29%3.34M | -31.52%1.4M | 225.50%4.53M |
| Operating profit | 111.75%8.22M | 180.20%9.57M | 12.53%3.88M | -60.07%3.42M | 28.60%3.45M | 6,634.65%8.55M | -1.07%2.68M | 103.86%127K | 162.14%2.71M | -134.82%-3.29M |
| Financing cost | -80.00%-9K | -25.00%-10K | -150.00%-5K | -14.29%-8K | 60.00%-2K | -16.67%-7K | ---5K | ---6K | ---- | ---- |
| Earning before tax | 111.79%8.21M | 180.57%9.56M | 12.45%3.88M | -60.13%3.41M | 28.76%3.45M | 6,962.81%8.55M | -1.25%2.68M | 103.68%121K | 162.14%2.71M | -134.82%-3.29M |
| Tax | -93.72%-1.27M | -143.61%-1.79M | 0.15%-653K | 55.95%-736K | -46.31%-654K | -291.33%-1.67M | 5.10%-447K | -268.10%-427K | -3,825.00%-471K | 94.36%-116K |
| After-tax profit from continuing operations | 115.45%6.94M | 190.75%7.77M | 15.40%3.22M | -61.15%2.67M | 25.25%2.79M | 2,346.73%6.88M | -0.45%2.23M | 91.01%-306K | 151.20%2.24M | -146.09%-3.4M |
| Earning after tax | 115.45%6.94M | 190.75%7.77M | 15.40%3.22M | -61.15%2.67M | 25.25%2.79M | 2,346.73%6.88M | -0.45%2.23M | 91.01%-306K | 151.20%2.24M | -146.09%-3.4M |
| Profit attributable to shareholders | 115.45%6.94M | 190.75%7.77M | 15.40%3.22M | -61.15%2.67M | 25.25%2.79M | 2,346.73%6.88M | -0.45%2.23M | 91.01%-306K | 151.20%2.24M | -146.09%-3.4M |
| Basic earnings per share | 150.00%0.005 | 189.47%0.0055 | 0.00%0.002 | -61.22%0.0019 | 0.00%0.002 | 2,550.00%0.0049 | 0.00%0.002 | 91.67%-0.0002 | 166.67%0.002 | -135.82%-0.0024 |
| Diluted earnings per share | 150.00%0.005 | 189.47%0.0055 | 0.00%0.002 | -61.22%0.0019 | 0.00%0.002 | 2,550.00%0.0049 | 0.00%0.002 | 91.67%-0.0002 | 166.67%0.002 | -135.82%-0.0024 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.